215 related articles for article (PubMed ID: 35344242)
1. Aluminum hydroxide adjuvant diverts the uptake and trafficking of genetically detoxified pertussis toxin to lysosomes in macrophages.
Jaldin-Fincati J; Moussaoui S; Gimenez MC; Ho CY; Lancaster CE; Botelho R; Ausar F; Brookes R; Terebiznik M
Mol Microbiol; 2022 May; 117(5):1173-1195. PubMed ID: 35344242
[TBL] [Abstract][Full Text] [Related]
2. Structure and compositional analysis of aluminum oxyhydroxide adsorbed pertussis vaccine.
Duprez J; Kalbfleisch K; Deshmukh S; Payne J; Haer M; Williams W; Durowoju I; Kirkitadze M
Comput Struct Biotechnol J; 2021; 19():439-447. PubMed ID: 33489011
[TBL] [Abstract][Full Text] [Related]
3. Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell type.
Rimaniol AC; Gras G; Verdier F; Capel F; Grigoriev VB; Porcheray F; Sauzeat E; Fournier JG; Clayette P; Siegrist CA; Dormont D
Vaccine; 2004 Aug; 22(23-24):3127-35. PubMed ID: 15297065
[TBL] [Abstract][Full Text] [Related]
4. Mg/Al-LDH as a nano-adjuvant for pertussis vaccine: a evaluation compared with aluminum hydroxide adjuvant.
Li D; Xu M; Li G; Zheng Y; Zhang Y; Xia D; Wang S; Chen Y
Nanotechnology; 2022 Mar; 33(23):. PubMed ID: 35189608
[No Abstract] [Full Text] [Related]
5. The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A.
Agnolon V; Bruno C; Leuzzi R; Galletti B; D'Oro U; Pizza M; Seubert A; O'Hagan DT; Baudner BC
Int J Pharm; 2015 Aug; 492(1-2):169-76. PubMed ID: 26149936
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
Berthold I; Pombo ML; Wagner L; Arciniega JL
Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073
[TBL] [Abstract][Full Text] [Related]
7. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
Front Immunol; 2019; 10():1520. PubMed ID: 31333656
[TBL] [Abstract][Full Text] [Related]
8. Genetically detoxified pertussis toxin displays near identical structure to its wild-type and exhibits robust immunogenicity.
Ausar SF; Zhu S; Duprez J; Cohen M; Bertrand T; Steier V; Wilson DJ; Li S; Sheung A; Brookes RH; Pedyczak A; Rak A; Andrew James D
Commun Biol; 2020 Aug; 3(1):427. PubMed ID: 32759959
[TBL] [Abstract][Full Text] [Related]
9. Silicon or Calcium Doping Coordinates the Immunostimulatory Effects of Aluminum Oxyhydroxide Nanoadjuvants in Prophylactic Vaccines.
Li M; Yao Z; Wang H; Ma Y; Yang W; Guo Y; Yu G; Shi W; Zhang N; Xu M; Li X; Zhao J; Zhang Y; Xue C; Sun B
ACS Nano; 2024 Jul; 18(26):16878-16894. PubMed ID: 38899978
[TBL] [Abstract][Full Text] [Related]
10. Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles.
Sun B; Ji Z; Liao YP; Wang M; Wang X; Dong J; Chang CH; Li R; Zhang H; Nel AE; Xia T
ACS Nano; 2013 Dec; 7(12):10834-49. PubMed ID: 24261790
[TBL] [Abstract][Full Text] [Related]
11. Crystalline and Amorphous Preparation of Aluminum Hydroxide Nanoparticles Enhances Protective Antigen Domain 4 Specific Immunogenicity and Provides Protection Against Anthrax.
Gogoi H; Mani R; Aggarwal S; Malik A; Munde M; Bhatnagar R
Int J Nanomedicine; 2020; 15():239-252. PubMed ID: 32021177
[TBL] [Abstract][Full Text] [Related]
12. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.
Visan L; Sanchez V; Kania M; de Montfort A; de la Maza LM; Ausar SF
Hum Vaccin Immunother; 2016 Sep; 12(9):2341-50. PubMed ID: 27104338
[TBL] [Abstract][Full Text] [Related]
13. Aluminum (oxy) Hydroxide Nanorods Activate an Early Immune Response in Pseudomonas aeruginosa Vaccine.
Chen Y; Yang F; Yang J; Hou Y; He L; Hu H; Lv F
ACS Appl Mater Interfaces; 2018 Dec; 10(50):43533-43542. PubMed ID: 30480997
[TBL] [Abstract][Full Text] [Related]
14. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
15. Genetically detoxified pertussis toxin induces superior antigen specific CD4 T cell responses compared to chemically detoxified pertussis toxin.
Surendran N; Pichichero M
Hum Vaccin Immunother; 2019; 15(5):1167-1170. PubMed ID: 30689515
[TBL] [Abstract][Full Text] [Related]
16. Advances in aluminum hydroxide-based adjuvant research and its mechanism.
He P; Zou Y; Hu Z
Hum Vaccin Immunother; 2015; 11(2):477-88. PubMed ID: 25692535
[TBL] [Abstract][Full Text] [Related]
17. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
18. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines.
Seubert A; D'Oro U; Scarselli M; Pizza M
Expert Rev Vaccines; 2014 Oct; 13(10):1191-204. PubMed ID: 25183193
[TBL] [Abstract][Full Text] [Related]
19. Multiplex immunoassay for in vitro characterization of acellular pertussis antigens in combination vaccines.
Agnolon V; Bruno C; Galletti B; Mori E; Ugozzoli M; Pergola C; O'Hagan DT; Baudner BC
Vaccine; 2016 Feb; 34(8):1040-6. PubMed ID: 26784684
[TBL] [Abstract][Full Text] [Related]
20. The Common vaccine adjuvant aluminum hydroxide up-regulates accessory properties of human monocytes via an interleukin-4-dependent mechanism.
Ulanova M; Tarkowski A; Hahn-Zoric M; Hanson LA
Infect Immun; 2001 Feb; 69(2):1151-9. PubMed ID: 11160013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
